TBC1D1 (TBC1 domain family member 1)

2003-02-01  

Identity

HGNC
LOCATION
4p14
LOCUSID
ALIAS
TBC,TBC1
FUSION GENES

Other Information

Locus ID:

NCBI: 23216
MIM: 609850
HGNC: 11578
Ensembl: ENSG00000065882

Variants:

dbSNP: 23216
ClinVar: 23216
TCGA: ENSG00000065882
COSMIC: TBC1D1

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000065882ENST00000261439Q86TI0
ENSG00000065882ENST00000261439B9A6J6
ENSG00000065882ENST00000402522B5MCJ2
ENSG00000065882ENST00000421339H7C380
ENSG00000065882ENST00000443855H7C0Z7
ENSG00000065882ENST00000446803C9JIE2
ENSG00000065882ENST00000508802Q86TI0
ENSG00000065882ENST00000510573H0Y8P0
ENSG00000065882ENST00000513936H0YA01
ENSG00000065882ENST00000615497A0JNU9

Expression (GTEx)

0
50
100
150
200

Pathways

PathwaySourceExternal ID
AMPK signaling pathwayKEGGhsa04152
AMPK signaling pathwayKEGGko04152
Vesicle-mediated transportREACTOMER-HSA-5653656
Membrane TraffickingREACTOMER-HSA-199991
Translocation of GLUT4 to the plasma membraneREACTOMER-HSA-1445148

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA447216SchizophreniaDiseaseClinicalAnnotationassociatedPD23364847
PA449061clozapineChemicalClinicalAnnotationassociatedPD23364847
PA450688olanzapineChemicalClinicalAnnotationassociatedPD23364847

References

Pubmed IDYearTitleCitations
381898232024TBC1D1 represses glioma progression by altering the integrity of the cytoskeleton.0
385292862024Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas.0
381898232024TBC1D1 represses glioma progression by altering the integrity of the cytoskeleton.0
385292862024Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas.0
342084712021Does TBC1D4 (AS160) or TBC1D1 Deficiency Affect the Expression of Fatty Acid Handling Proteins in the Adipocytes Differentiated from Human Adipose-Derived Mesenchymal Stem Cells (ADMSCs) Obtained from Subcutaneous and Visceral Fat Depots?3
342084712021Does TBC1D4 (AS160) or TBC1D1 Deficiency Affect the Expression of Fatty Acid Handling Proteins in the Adipocytes Differentiated from Human Adipose-Derived Mesenchymal Stem Cells (ADMSCs) Obtained from Subcutaneous and Visceral Fat Depots?3
318163122020WNK1 phosphorylation sites in TBC1D1 and TBC1D4 modulate cell surface expression of GLUT1.10
318955962020Sex and fiber type independently influence AMPK, TBC1D1, and TBC1D4 at rest and during recovery from high-intensity exercise in humans.6
330878482020TBC1D1 interacting proteins, VPS13A and VPS13C, regulate GLUT4 homeostasis in C2C12 myotubes.12
318163122020WNK1 phosphorylation sites in TBC1D1 and TBC1D4 modulate cell surface expression of GLUT1.10
318955962020Sex and fiber type independently influence AMPK, TBC1D1, and TBC1D4 at rest and during recovery from high-intensity exercise in humans.6
330878482020TBC1D1 interacting proteins, VPS13A and VPS13C, regulate GLUT4 homeostasis in C2C12 myotubes.12
278266582017A Tbc1d1 (Ser231Ala)-knockin mutation partially impairs AICAR- but not exercise-induced muscle glucose uptake in mice.17
278266582017A Tbc1d1 (Ser231Ala)-knockin mutation partially impairs AICAR- but not exercise-induced muscle glucose uptake in mice.17
265721372016Whole-exome sequencing identifies mutations of TBC1D1 encoding a Rab-GTPase-activating protein in patients with congenital anomalies of the kidneys and urinary tract (CAKUT).13

Citation

Dessen P

TBC1D1 (TBC1 domain family member 1)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/42476/tbc1d1-(tbc1-domain-family-member-1)